Obinutuzumab latest price in 2023

Obinutuzumab is a targeted chemotherapy drug used to treat certain blood cancers. Otuzumab is a biologic drug called a monoclonal antibody that targets and attaches to CD20, a protein found on the surface of a type of white blood cell called B cells. B cells, also called B lymphocytes, usually help your body fight infections, but some people produce abnormal numbers of B cells, which can lead to cancer.

Otuzumab works by binding to normal and cancerous B cells, marking them for destruction, calling on your own immune system cells to attack and divide the taggedB cells, and activating processes within the B cells that instruct them to die. Otuzumab was approved by the U.S. Food and Drug Administration (FDA) in 2013 for the treatment of patients with chronic lymphocytic leukemia and follicular lymphoma. It can also be used with chemotherapy drugs to increase the therapeutic effect of the drugs, such as chlorambucil, bendamustine, etc.

The original drug of Otuzumab has been launched in China and has entered the scope of medical insurance, but it is only reimbursed for patients who meet the indications. Specifications The price of 1000mg (40ml)*1 bottle may be around 9,000 yuan, which is a strictly controlled drug. The price of the Turkish version of Otuzumab Specifications1000mg/40ml per box listed overseas may be around RMB 10,000 (the price may fluctuate due to the exchange rate). The ingredients of the original drugs sold domestically and abroad are basically the same. There is currently no generic version of Otuzumab produced and launched. For more drug information and specific prices, please consult the medical consultant of Yaode.